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This case report describes a child with Castleman disease. We present an overview of the disease, the
investigation leading to the diagnosis, the laparoscopic approach for surgical treatment and the follow
up. This rare entity must be considered in cases of long-standing abdominal pain, cross-sectional imaging
is beneﬁcial and we support the use of laparoscopic intervention in the treatment of unifocal abdominal
Castleman disease.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Abdominal pain is common in children and there are a vast
number of differential diagnoses. Many conditions are self-limited
and many others are easily recognized during an evaluation.
Castleman disease is an un-common disease that can cause
unspeciﬁc abdominal pain in children and may not be readily
understood by the attending physician due to its rarity.
We report a seven-year-old boy with long-standing abdominal
pain that was diagnosed with unifocal Castleman disease and was
cured after a laparoscopic resection of the mass.1. Case report
This boy was admitted to the department of pediatric gastro-
enterology due to suspicion of sero-negative celiac disease for an
esophagogastroduodenoscopy (EGD) and duodenal biopsies. He
suffered from loose stool, tenesmi, urgency and recurrent abdom-
inal pain since the age of three. Nine months prior to this admissionrgery, Q3:03, Astrid Lindgren
el.: þ46 851777367, þ46
vensson).
Inc. This is an open access article uthe general practitioner tried gluten-free diet for three months
which resulted in resolution of pain, diarrhea and the boy feeling
more alert than previously. But as he was conﬁrmed sero-negative
to gliadin antibodies he had been on normal diet for 6 months
when he was ﬁrst seen at our department.
The EGD was macroscopically normal and the histopathology
showed chronic bulbitis and antrum gastritis but no signs of celiac
disease. On abdominal examination at follow-up, the abdomen was
soft andwithout tendernessduringpalpation,but apossiblemasswas
felt in the left lowerquadrant. At rectal examination a fecal lumpwere
palpated in ampulla recti. Laboratory values: B-Hemoglobin (HB)
11.4g/dl, platelet count (PLT)633109/l,whitebloodcell count (WBC)
13.1  109/l, S-Albumin 3.4 g/dl, C-reactive protein (CRP) 16 mg/l,
erythrocyte sedimentation rate (ESR) 23 mm/h, S-iron 5 mmol/l, S-
Ferritin 43 mg/l and P-Orosmucoid 1.6 g/l. Gliadin IgA-antibodies
<15E/ml andTransglutaminase IgA-antibodies<5E/ml. Thepalpable
mass combined with a fecal lump found during rectal digital exami-
nationwas suggestive of constipation. The boy was therefore treated
with Macrogol and he was put on a cow’s milk-free diet.
Five months later the patient had a positive weight
gain and the abdominal pain had disappeared and there was no
palpable lump in the abdomen, but his biochemical parameters still
showed inﬂammation and this combined with a raised level ofnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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scopy with the suspicion of Crohn’s disease. The EGD was macro-
scopically normal and histopathology showed focally enhanced
chryptitis, a lymphatic plaque and occasional HP-species. The
ileocolonoscopy showed only diffuse macroscopic ﬁndings in the
colon. In the rectal biopsies slight elevated numbers of eosinophilic
and inﬂammatory cells was found. In conclusion there were no
signs of inﬂammatory bowel disease. Immunohistochemistry for
Langerhans cell histiocytosis was negative. For further broad
assessment we performed both an ultrasonography (US) of
the upper part of the abdomen and a small bowel follow-through,
both were normal. Further investigation with Chest x-ray and
auto-antibodies (S-ASCA/ANCA, S-ANA, S-RF-IgA, S-smooth mus-
cle-IgG and S-Mitochondria-IgG) were all normal.
Six months later, due to recurrent abdominal pain, fatigue
and raised inﬂammatory markers including a slightly elevated
f-Calprotectin a capsule-enteroscopy, a new gastro-ileocolonoscopy
and a Tc-99 m labeled-WBC scintigraphy was performed to exclude
Crohn’s disease in the small bowel. A urine-sample was positive for
protein but not enough to explain the low albumin value. All other
investigations were normal.
He had abdominal pain for most of this year-long investigation
but not so severe that it led to any in-patient stay or surgical
intervention.
After 16 month, at age nine, due to increasing pain a computed
tomography-scan of the abdomen was performed and it revealed aFig. 1. Computed tomography-scan of abdomen prior to surgery.mesenteric mass in the central part of the abdomen, below the part
of the abdomen that was investigated with the previous US, but no
other suspicious tumors (Fig. 1). A repeated contrast-enhanced US
at this time showed a single enlarged lymph node, about 4.5 cm in
diameter corresponding to the above mentioned mass.
This ﬁnding led to a referral to the paediatric oncologist. The
investigation included an ultrasound-guided ﬁne-needle biopsy
that showed a reactive lymphatic cell population and a bilateral
bone-marrow aspiration that showed a reactive cell population
without increased blast fraction. At this point Castleman disease
was suspected. Both for deﬁnitive diagnosis and with the ambition
of a curative treatment there was an indication for surgery. The
suspicious lymph node was located in the central small bowel
mesentery just at the aortic bifurcation and the inferior vena cava.
At time of surgery the ESR was 28 mm/h, CRP 62 mg/L, B-HB
98 g/L, MCV 72 ﬂ and PLT 448  109/L.
We used minimal access surgery with a 12 mm blunt port at the
umbilicus and three 5-mm STEP-ports (Covidien, USA). We used an
open introduction of the umbilical port. The lymph node was
readily identiﬁable just above the level of the umbilicus. The
overlying peritoneum was opened with monopolar cautery.
Moderate traction was applied on the enlarged lymph node and it
was dissected free from underlying vascular structures with a
combination of blunt and sharp dissection. With the intention of
keeping the lymph node in one piece for histological examination
we extracted the specimen in an Endo-Catch bag (Covidien, USA)
through an “inverted” Tan-Bianchi incision [1]. The lymph node
measured 4.5  3.3  2.6 cm. The post-operative recovery was
uneventful and he returned home the same day as the operation.
The pathology report shows lymphoid tissue with the diagnosis
of hyaline vascular Castleman disease. There were no signs of
lymphoma.
Follow up was performed with repeated US and biochemical
markers. Already four weeks after the operation, all deranged
biochemical markers had normalized; ESR 9 mm/h, CRP <1 mg/L,
B-HB 119 g/L, MCV 74 ﬂ and PLT 305  109/L. Six month post-op the
pain had completely resolved. For the ﬁrst three years of follow-up,
some enlarged lymph nodes could be seen in the mesentery with
US. For the last two years, no enlarged nodes have been seen.
In summary, no complications have been seen during ﬁve years
of follow-up.
2. Discussion
We present this case to describe the rare diagnosis of Cas-
tleman disease, to advocate the use of cross-sectional imaging
during the investigation of long-lasting abdominal pain in chil-
dren and to recommend the use of minimal access surgery for
exploration and intervention in the mesentery and retro-perito-
neum in children.
Castleman disease is a lymphoproliferative disease, also known
as Angiofollicular hyperplasia. It was ﬁrst described by Benjamin
Castleman and co-workers in 1954 [2] and the hallmark of the
disease is a follicular hyperplasia of lymph nodes with abnormally
increased interfollicular vascularity. There are three histopatho-
logical types of the disease, the hyaline vascular, the plasmacytic
and the mixed types. The hyaline vascular type occurs in 80e90% of
cases, is usually unifocal and is relatively benign. In this type the
lymph node germinal centers are poorly formed with dysplastic/
atrophic CD21þ follicular dendritic cell networks surrounded by an
expanded mantle zone consisting of rims of small CD20þ
lymphocytes arranged in an onion skin manner. The plasmacytic
occurs in 10e15% of cases, characterized by both more numerous
and larger hyperplastic follicles which has more expanded mantle
zones compared to the hyaline vascular type. The least common
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plasmacytic types Castleman disease. An alternative classiﬁcation is
unifocal or multifocal disease. The unifocal disease is almost
exclusively of the hyaline vascular type.
Castleman disease can mimic Crohn’s disease as described in
adults [3]. Earlier reports have described Castleman disease as
differential diagnosis to other GI-disease’s like pancreatic islet cell
tumor [4], Hepatocellular Carcinoma [5], Ulcerative colitis [6],
gastric sub-mucosal tumor [7], PSC [8] or in combination with ul-
cerative colitis [9], Crohn’s disease [10], autoimmune pancreatitis
[11] or bleeding oesophageal varices [12].
In cases of unifocal disease, symptoms are due to a mass effect of
bulky lymphadenopathy. In 90e95% of cases surgical resection is
curative and usually there is no progression to lymphoma
or association with other tumors [13]. The prognosis is excellent
with a ﬁve year survival of close to 100%. In cases of multifocal
disease, symptoms are more generalized and often more severe.
The hyaline vascular type is the most common in childhood and
presents as a slowly growing mass in most cases.
Surgical resection is the preferred treatment of unifocal Castle-
man disease even if radiotherapy is described with good results
[14]. There are reports of laparoscopic resection of Castleman dis-
ease in the literature, the ﬁrst presented in 2003 [15].
There are no reports in the literature that describes laparoscopic
extirpation of a solitary lymph node with Castleman disease in
children. To us, the beneﬁts of minimal access surgery including
enlargement of the visual ﬁeld aided by a 30 laparoscope and small
instruments makes this modality superior to an open operation
through a modest abdominal incision.
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